AMICUS THERAPEUTICS, INC. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
3/A
4
4/A
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFM14A
EFFECT
FWP
PRE 14A
PREM14A
REGDEX
REGDEX/A
RW
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4/A | 4/A | 0000950170-24-032406 | Mar 15, 2024 | Jan 9, 2024 |
| 4/A | 4/A | 0000950170-24-032402 | Mar 15, 2024 | Jan 9, 2024 |
| 4/A | 4/A | 0000950170-24-032404 | Mar 15, 2024 | Jan 9, 2024 |
| 4 | 4 | 0000950170-24-029458 | Mar 11, 2024 | Mar 7, 2024 |
| 4 | 4 | 0000950170-24-027334 | Mar 6, 2024 | Mar 4, 2024 |
| 4 | 4 | 0000950170-24-027339 | Mar 6, 2024 | Mar 5, 2024 |
| 144 | — | 0001950047-24-001878 | Mar 5, 2024 | — |
| 4 | 4 | 0000950170-24-026265 | Mar 5, 2024 | Mar 1, 2024 |
| 4 | 4 | 0000950170-24-026266 | Mar 5, 2024 | Mar 1, 2024 |
| 144 | — | 0001950047-24-001795 | Mar 4, 2024 | — |
| 144 | — | 0001950047-24-001691 | Mar 1, 2024 | — |
| 144 | — | 0001950047-24-001672 | Mar 1, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-028461 | Feb 28, 2024 | — |
| 10-K | 10-K | 0001178879-24-000003 | Feb 28, 2024 | Dec 31, 2023 |
| 4 | 4 | 0000950170-24-017267 | Feb 20, 2024 | Feb 15, 2024 |
| 4 | 4 | 0000950170-24-017264 | Feb 20, 2024 | Feb 15, 2024 |
| 4 | 4 | 0000950170-24-017265 | Feb 20, 2024 | Feb 15, 2024 |
| 144 | — | 0001950047-24-000987 | Feb 15, 2024 | — |
| 144 | — | 0001950047-24-000975 | Feb 15, 2024 | — |
| 144 | — | 0001950047-24-000973 | Feb 15, 2024 | — |
| SC 13G/A | AMICUS THERAPEUTICS, INC. | 0000902664-24-001616 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-023783 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-036380 | Feb 14, 2024 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-24-020274 | Feb 13, 2024 | — |
| SC 13G | SEC SCHEDULE 13G | 0000902219-24-000043 | Feb 8, 2024 | — |
| 4 | 4 | 0000950170-24-012843 | Feb 8, 2024 | Feb 6, 2024 |
| 144 | — | 0001950047-24-000699 | Feb 6, 2024 | — |
| 4 | 4 | 0000950170-24-011433 | Feb 5, 2024 | Feb 1, 2024 |
| 4 | 4 | 0000950170-24-011434 | Feb 5, 2024 | Feb 1, 2024 |
| 144 | — | 0001950047-24-000582 | Feb 1, 2024 | — |
| 144 | — | 0001950047-24-000584 | Feb 1, 2024 | — |
| SC 13G/A | — | 0001086364-24-004294 | Jan 26, 2024 | — |
| 4 | 4 | 0000950170-24-007065 | Jan 24, 2024 | Jan 22, 2024 |
| 144 | — | 0001950047-24-000399 | Jan 22, 2024 | — |
| 4 | 4 | 0000950170-24-005451 | Jan 18, 2024 | Jan 16, 2024 |
| 144 | — | 0001950047-24-000317 | Jan 16, 2024 | — |
| 4 | 4 | 0000950170-24-004042 | Jan 11, 2024 | Jan 9, 2024 |
| 4 | 4 | 0000950170-24-004043 | Jan 11, 2024 | Jan 9, 2024 |
| 4 | 4 | 0000950170-24-004044 | Jan 11, 2024 | Jan 9, 2024 |
| 4 | 4 | 0000950170-24-004045 | Jan 11, 2024 | Jan 9, 2024 |
| 4 | 4 | 0000950170-24-004046 | Jan 11, 2024 | Jan 9, 2024 |
| 144 | — | 0001950047-24-000248 | Jan 10, 2024 | — |
| 144 | — | 0001950047-24-000226 | Jan 9, 2024 | — |
| 4 | 4 | 0000950170-24-003440 | Jan 9, 2024 | Jan 8, 2024 |
| 144 | — | 0001950047-24-000225 | Jan 9, 2024 | — |
| 4 | 4 | 0000950170-24-003441 | Jan 9, 2024 | Jan 8, 2024 |
| 144 | — | 0001950047-24-000191 | Jan 8, 2024 | — |
| 8-K | FORM 8-K | 0001104659-24-002057 | Jan 8, 2024 | Jan 7, 2024 |
| 144 | — | 0001950047-24-000192 | Jan 8, 2024 | — |
| 4 | 4 | 0000950170-24-002587 | Jan 5, 2024 | Jan 4, 2024 |